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Abstract 20 
Inflammatory reactions are the most critical pathological processes occurring after 21 
spinal cord injury (SCI). Activated microglia/macrophages have either detrimental or 22 
beneficial effects on neural regeneration based on their functional polarized M1/M2 23 
subsets. However, the mechanism of microglia/macrophages polarization to M1/M2 at 24 
the injured spinal cord environment remains unknown. In this study, wild type (WT) 25 
or aldose reductase (AR) knockout (KO) mice were subjected to SCI by spinal crush 26 
injury model. The expression pattern of AR, behavior tests for locomotor activity, and 27 
lesion size were assessed at between 4 hours and 28 days after SCI. we found that the 28 
expression of AR is upregulated in microglia/macrophages after SCI in WT mice. In 29 
AR KO mice, SCI led to smaller injury lesion areas compared to WT. AR 30 
deficiency-induced microglia/macrophages induce the M2 rather than the M1 31 
response and promote locomotion recovery after SCI in mice. In vitro experiments, 32 
microglia cell lines (N9 or BV2) were treated with AR inhibitor (ARI), Fidarestat. AR 33 
inhibition caused 4-Hydroxynonenal (HNE) accumulation, which induced the 34 
phosphorylation of cAMP-responsive binding element (CREB) to promote Arg1 35 
expression. KG501, the specific inhibitor of phosphorylated CREB could cancel the 36 
upregualtion of Arg 1 by ARI or HNE stimulation. Our results suggest that AR works 37 
as a switch which can regulate microglia by polarizing cells to either the M1 or the 38 
M2 phenotype under M1 stimulation based on its states of activity. We suggest that 39 
inhibiting AR may be a promising therapeutic method for SCI in the future. 40 
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Introduction 43 
Spinal cord injury (SCI) is one of the most debilitating diseases with poor prognosis 44 
worldwide. Traumatic damage triggers a complex local inflammatory response, a 45 
critical pathophysiological process following a secondary injury after SCI. At the 46 
spinal cord lesion site, microglia/macrophages derived from both residential microglia 47 
and hematogenous macrophages or from activated microglia and infiltrated 48 
macrophages, respectively, cannot be distinguished based on their morphology or 49 
specific molecular markers [13]. Microglia/macrophages have either detrimental or 50 
beneficial effects on neural regeneration based on their two extreme functional 51 
polarized subsets, “classically activated” pro-inflammatory (M1) or “alternatively 52 
activated” anti-inflammatory (M2) cells [6-8, 18, 23]. In response to 53 
lipopolysaccharide (LPS) and the pro-inflammatory cytokine interferon-Ȗ (IFN-Ȗ), 54 
macrophages undergo M1 polarization characterized by the expression of 55 
pro-inflammatory cytokines [interleukin (IL)-12, IL-1ȕ and tumor necrosis factor 56 
(TNF)-α] and cytotoxic mediators (reactive oxygen and nitrogen species), as well as 57 
increase their phagocytic and antigen-presenting capacity. In contrast, activating 58 
macrophages in the presence of IL-4 or IL-13 undergo M2 polarization characterized 59 
by the expression of anti-inflammatory cytokines such as transforming growth factor 60 
(TGF)-ȕ and IL-10, which contribute to the termination of inflammation [13, 28, 45]. 61 
Kigerl et al. reported that most microglia/macrophages are polarized to M1 cells, with 62 
only a transient and small number in M2 polarization [23]. In vitro, they showed that 63 
M1 macrophages are neurotoxic and possess only moderate axon growth-promoting 64 
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effects. In contrast, M2 macrophages can promote long-distance axon growth, even in 65 
the present of potent growth inhibitory substrates [23]. 66 
One of the well-characterized pathological processes occurring early after SCI is the 67 
formation of reactive nitrogen species (RNS) and reactive oxygen species (ROS) [9, 68 
30]. RNS and ROS cause lipid oxidation as well as nitrative and oxidative damage to 69 
proteins and nucleic acids, leading to neuronal loss by necrosis or apoptosis [30, 54]. 70 
Microglia/macrophages are the major cells that produce neurotoxic RNS and ROS 71 
after SCI [14]. Oxidative stress-induced inflammation is a major contributor to 72 
secondary injury after SCI [9]. ROS-mediated activation of redox-sensitive 73 
transcription factors, such as nuclear factor-kappa B (NF-κB) and activator protein 74 
(AP)-1, as well as subsequent expression of pro-inflammatory cytokines, chemokines, 75 
and growth factors, are characteristics of inflammatory diseases [5, 48]. The 76 
pro-inflammatory cytokines TNF-α and IL-1ȕ, which are up-regulated immediately 77 
after SCI combining with the ligands of pattern recognition receptors (PRRs), such as 78 
high mobility group box protein (HMBG1) and LPS, can cause 79 
microglia/macrophages to enter an overactive state and begin releasing ROS [13, 14, 80 
23]. Cytokines and LPS cause oxidative stress to form toxic lipid aldehydes such as 81 
4-hydroxynonenal (HNE), which triggers multiple signaling cascades that variably 82 
affect cell growth, differentiation, and apoptosis through lipid peroxidation [36]. 83 
Aldose reductase (AKR1B1, AR) belongs to the aldo-keto reductase (AKR) 84 
superfamily, which includes several enzymes that catalyze oxidation and reduction 85 
reactions involved in various cellular processes [48]. AR is the only enzyme 86 
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responsible for reducing glucose to sorbitol in the polyol pathway of glucose 87 
metabolism and identified as the chief facilitator of hyperglycemic injury in secondary 88 
diabetic complications such as cataractogenesis, retinopathy, neuropathy, nephropathy, 89 
and cardiovascular diseases [39]. Recent studies have suggested that glucose may be 90 
an incidental substrate of AR, which appears to be good at catalyzing the reduction of 91 
a wide range of aldehydes generated from lipid peroxidation. Several reports showed 92 
that AR, in addition to reducing glucose, efficiently reduces the lipid 93 
peroxidation-derived aldehydes such as HNE, were thought to be the preferred 94 
physiological substrates with higher affinity than glucose [48]. AR catalyzes the 95 
reduction of lipid aldehydes and their reduced glutathione (GSH) metabolites both in 96 
vitro and in vivo [47]. Pharmacological inhibition or small interfering RNA (siRNA) 97 
ablation of AR prevented the biosynthesis of TNF-α, IL-1ȕ, IL-6, 98 
macrophage-chemoattractant protein (MCP)-1, cyclooxygenase-2 (Cox-2), and 99 
prostaglandin E2 (PGE2) in LPS-activated RAW264.7 murine macrophages. AR 100 
inhibition or ablation significantly attenuated LPS-induced activation of protein 101 
kinase C (PKC) and phospholipase C (PLC), nuclear translocation and 102 
phosphorylation of NF-κB, and proteolytic degeneration of IκBα in macrophages [38]. 103 
These results indicate that AR can promote LPS-induced inflammatory signals in 104 
macrophages by promoting NF-κB-dependent expression of inflammatory cytokines 105 
and chemokines. Whether AR plays a role in M1 or M2 polarization of 106 
microglia/macrophages and in neuroinflammation after SCI remains unclear. In this 107 
study, we found that mRNA and protein levels of AR increased in a time-dependent 108 
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manner after SCI. In AR−/− mice, activated microglia/macrophages at the injured site 109 
were prone to M2 rather than M1 polarization during early stages of SCI. HNE, the 110 
substrate of AR, accumulated in microglia treated with AR inhibitor inducing 111 
transcript factor cAMP-responsive element-binding protein (CREB) upregulation and 112 
phosphorylation, which promoted microglia polarization to M2.  113 
Materials and Methods 114 
Animals and SCI model  115 
AR-/- mice generated previously and backcrossed to C57BL/6 mice for more than 10 116 
generations, which are considered to be congenic with C57BL/6 mice, were used 117 
(n=53) [21]. Age-matched normal C57BL/6 (n=55) (SLAC, Shanghai, China) were 118 
used as control wild-type mice (AR+/+). Mice were housed in a specific pathogen-free 119 
(SPF) environment at the animal facility of Department of Neurobiology, the Fourth 120 
Military Medical University. All procedures were conducted under guidelines 121 
approved by the Fourth Military Medical University Animal Care and Use 122 
Committee. Anesthetized mice with 1% sodium pentobarbital (Sigma-Aldrich, 40 123 
mg/kg) received a severe spinal crush injury as described previously with certain 124 
modifications [33]. Briefly, a laminectomy was performed at vertebral midthoracic 125 
level T8-T10 leaving dura intact. SCI was made at the level of T8 by compressing the 126 
cord laterally from both sides for 20 s with Number 5 Dumont forceps (Fine Science 127 
Tools) modified with a spacer of 0.25 mm to produce severe injury. Sham group was 128 
generated by only performing laminetomy but no compressing the cord. 129 
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Postoperatively, mice received manual bladder evacuation twice a day to prevent 130 
urinary tract infections until normal voiding reflexes returned. 131 
Behavioural assessment 132 
Gross locomotor recovery after SCI was assessed using the Basso Mouse Scale  133 
(BMS) hindlimb locomotor test for mice [2]. For 1 week before surgery, mice were 134 
acclimated to the testing field. At 0, 3, 5, 7, 14 and 28 day post injury (dpi), mice were 135 
placed in this field and observed with video record for 4 min. Each hind limb was 136 
scored by two investigators blinded to the treatment protocol.  137 
Estimation of lesion area 138 
Spaced serial 10 μm thick sections 100 μm apart were stained with Luxol Fast Blue 139 
(LFB, Sigma-Aldrich) [4]. Briefly, the sections were dehydrated and incubated in 140 
0.1% LFB dissolved in 95% ethanol at 60°C overnight. Stained sections were cooled 141 
at RT and differentiated in 0.05% lithium carbonate and 70% ethanol. Sections were 142 
then counterstained with 0.1% Cresyl Violet (Sigma-Aldrich) at 60°C for 10 min and 143 
mounted in neural resin . Digital images were acquired using a DP70 digital camera 144 
(Olympus) mounted on a BX51 Olympus microscope equipped with a 10× objective. 145 
Five random sections were quantified per mouse and three mice of each kind were 146 
measured per group. Quantification of LFB stained areas was performed using 147 
Photoshop CS3 software. 148 
Cell cultures 149 
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Microglial cell lines culture 150 
The murine microglial cell line N9 (keeping in our lab) or BV2 was cultured in 151 
Dulbecco's Modified Eagle's medium (DMEM) (Gibco) supplemented with 5% Fetal 152 
Bovine Serum (FBS; Gibco), 2 mM L-Glutamine 100 U/ml penicillin and 100 μg/ml 153 
streptomycin. 5×105 cells were seeded onto 12-well plates. To detect the polarization 154 
of N9 microglia, cells were treated with LPS (100 ng/ml; Sigma-Aldrich) or IL-4 (20 155 
ng/ml; R&D Systems), respectively, combined with Fidarestat β0 μM (Lot. γ0800β, 156 
Sanwa Kagaku Kenkyusho, Nagoya, Japan) following two strategies. One was first to 157 
stimulate N9 cells with the above cytokines for 24 h, respectively, and then add ARI 158 
for another 24 h. The other was first to treat N9 cells with ARI for 24 h and then add 159 
the cite cytokines, respectively, for another 24 h. After those treatments, N9 cells was 160 
washed with D-Hank’s solution for γ times and harvested for further analysis with 161 
qPCR or Western blot. 162 
Primary cortical neurons cultures 163 
Primary cortical neurons were prepared from wild type (C57BL/6) and AR deficient 164 
mouse at E15 [15]. Using aseptic technique, the fetal brains were removed and 165 
transferred into ice-cold D-Hank’s medium without Ca2+ and Mg2+. After, bilateral 166 
cortices were mechanically separated and the meninges were carefully removed using 167 
fine forceps (Sigma-Aldrich, style #7). Then the cerebral cortex was minced using 168 
sterile iridectomy scissors. These pieces were incubated in Ca2+ and Mg2+ free 169 
D-Hank’s balanced salt solution with 0.125 % trypsin and 0.1% DNase at 37 °C for 170 
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15 min. The enzymatic digestion was followed by a brief mechanical trituration using 171 
polished Pasteur pipettes and centrifuged at 800 rpm for 5 min. Cells were suspended 172 
in Neurobasal A (Gibco) supplemented with B27 (Gibco) and 2 mM L-glutamine. Cell 173 
suspension were seeded in poly-L-lysine (β5 μg/ml, Sigma) coated 6-well culture 174 
plates at a density of 4 × 104 cells/cm2 at 37 °C/5% CO2 for 7-14 d culture. The cell 175 
populations consisted of >95% neurons before used, which was determined by 176 
immunocytochemical stain with anti Neuron- specific ȕ-tubulin Ⅲ (data not shown) 177 
[46]. 178 
Primary astrocytes cultures 179 
Primary astrocytes were cultured from the cerebral cortex of 1-2 d postnatal mouse 180 
pups [17]. The cerebral cortices were dissected and trypsinized as indicated above for 181 
the primary neurons cultures. Cells were suspended in DMEM medium supplemented 182 
with 10% FBS (Gibco), 2 mM glutamine, 50 U/ml Penicillin and 50 μg/ml 183 
Streptomycin (Glibco). Cells were plated on PLL coated 75 cm2  culture flasks at a 184 
density of 1 × 105 cells/cm2 and cultured in 5% CO2 at 37 °C. After 7-10 d incubation, 185 
cultures were purified by shaking for 20 h on an orbital shaker (180 rpm) at 37°C, 186 
resulting in cultures of 95% GFAP-positive cells. Purified astrocytes were digested by 187 
trypsinization, and cells were again plated at the density of 5×105/cm2 onto PLL 188 
coated 6-well plates and incubated in 5% CO2 at 37 °C for two days before used. 189 
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Oligodendrocyte cultures 190 
Oligodendrocyte precursor cells (OPC) were generated from primary mixed glial 191 
cultures above mentioned as described previously [49, 55]. Briefly, after ten days 192 
culture in DMEM medium with 10% FBS (Gibco) and supplemented with 2 mM 193 
glutamine, 50 μg/ml Streptomycin and 50 U/ml Penicillin. Oligodendrocyte precursor 194 
cells were shaking off based on the different adhesion properties of different glial cell 195 
types. Cell cultures were shaken first at 200rpm, 37°C for 30min and rinced with fresh 196 
DMEM medium with 10% FBS (Gibco) and supplemented with 2 mM glutamine, 197 
50 μg/ml Streptomycin and 50 U/ml Penicillin. After cells were cultured for another 198 
14-16 h, cell cultures were shaken at 280 rpm, 37°C for 18-20 h to collect the OPC. 199 
Precursor cells were obtained by sequential dislodging procedure. Purified OPC were 200 
plated onto PLL coated 6-well plates at the density of 4× 104 cells/cm2 and cultured  201 
in Satomedium ( DMEM/F12 supplemented with 4 mM Glu, 0.1 mM sodium 202 
pyruvate, 0.1% BSA, 50μg/ml transferrin, 5μg/ml Insulin, 30 nM sodium selenate, 10 203 
nM Vitamin H and 10 nM hydrocortisone ) supplemented with 10 ng/ml PDGF-AA 204 
and 10 ng/ml bFGF to promote cell growth. OPC were cultured in above expansion 205 
medium for 2-3 d and passaged with DMEM/F12 supplemented with 0.01% EDTA，206 
0.2 mg/ml DNase and 5 μg/ml insulin. The supernatant was collected and NG2+ cells 207 
were plated onto PLL coated 6-well plates at the density of 8× 104 cells/cm2  in 208 
differentiation medium which contains Satomedium supplemented with 15 nM 209 
triiodothyronine (T3), 10 ng/ml ciliary neurotrophin factor (CNTF), and 5 μg/ml 210 
N-acetyl-l-cysteine (NAC) for 6 days before used. 211 
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Primary microglia cultures 212 
Primary microglia cultures were also obtained from the cerebral hemispheres of 213 
newborn mouse brains (P1-2) as previously described [3, 24]. In brief, mixed glial 214 
cells were seeded onto PLL coated culture flasks at a density of 1 × 105 cells/cm2. Two 215 
weeks later, microglia were shaken off at 200 rpm for 30min. Highly enriched 216 
microglial suspension were collected and filtered through 41 μm cell strainer. After 217 
centrifugation at 800 rpm for 5 min, cells were resuspended in DMEM medium with 218 
10% FBS, and plated onto 6-well plates at a density of 2 × 105 cells/cm2. The purity of 219 
cells obtained was harvested > 95% based on staining with Iba-1 antibody before 220 
used.  221 
When the purified neural cells reached 80% confluence, TNF-α+IFN-Ȗ or LPS 222 
were pulsed into culture medium for another 24 h incubation. Purified neural  were 223 
harvested for AR level detection with qPCR.  224 
Immunohistochemistry 225 
Mice were killed by injection of an overdose of 2% sodium pentobarbital. The 226 
animals were transcardially perfused with ice-cold saline followed by 4% 227 
formaldehyde in 0.1 M phosphate buffer, pH 7.4, for at least 15 min at room 228 
temperature (RT). After perfusion, the spinal cords were dissected out and postfixed 229 
4-6 h at 4°C in the same solution used for perfusion. Spinal cord tissue was then 230 
immersed into 20% sucrose solution in 0.1 M phosphate buffer, pH 7.3, at 4°C for 231 
cryoprotection. Tissues were embedded in Tissue Tek (Sakura Finetek, Zoeterwoude, 232 
The Netherlands), cut transversely or longitudinally into 10-μm slices in a cryostat, 233 
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mounted onto glass slides, and store at -20 °C for further processing.  234 
   The sections were blocked with 1% bovine serum albumin containing 0.3% triton 235 
X-100 for 1 h. Sections were then incubated with primary antibodies (see Table 1) 236 
overnight at 4 °C. Then sections were incubated with appropriate secondary antibody 237 
for 2 h at room temperature. Images were acquired by using FV 1000 confocal system 238 
(Olympus, Japan). 239 
To detect the accumulation of HNE after given ARI, we treated cultured BV2 and 240 
N9 microglia with Fidarestat at 0, β0, γ0, and 40 μM for 24 h. After washing 3 times 241 
with PBS, the cells were fixed with 4% formaldehyde for 10 min at RT. Cells were 242 
incubated with rabbit anti-HNE pAb (abcam) overnight at 4 oC. After washing with 243 
PBS 3 times, the FITC labeled anti-rabbit IgG were incubated for 2 h. The density of 244 
fluorescence were judged under BX53 microscopy (Olympus, Japan) with same 245 
expose time or with fluorescent density scan˄excitation wavelength 493 nm and 246 
emission wavelength 518 nm˅  by Infinite M200 PRO (TECAN, Swiss). All 247 
antibodies and their dilutions used in IHC in this study were listed in Table 1.  248 
Table 1. Antibodies for IHC and WB 249 
   Dilution 
Antibodies Host Vendor IHC WB 
AR Mouse Santa 1:200 1:1000 
ȕ-actin Mouse Sigma N/A 1:8000 
iNOS Rabbit abcam 1:500 1:500 
Arginase 1 Goat Santa 1:100 1:1000 
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 250 
Quantitative Real-time PCR 251 
The method of QRT-PCR was carried out as our previously description with slight 252 
modifications [56]. Brifely, mice were sacrificed 1, 3, 7, 14 and 21 days after SCI 253 
with an overdose of 2% pentobarbital sodium intraperitoneal injection. An 1cm spinal 254 
cord segment containing the injured site in the middle was removed quickly for RNA 255 
isolation. Controled mice were sacrificed after the operation as well. 256 
Total RNA was extracted using TRizol reagent (Invitrogen) according to the 257 
manufacturer’s instructions. The concentration of RNA was measured by UV 258 
absorbance at 260 and 280 nm (260/280) while the quality was checked by gel 259 
NF-κB 
pNF-κB 
CREB 
Rabbit 
Rabbit 
Rabbit 
Anbo 
Cell Signaling 
Epitomics 
N/A 
N/A 
N/A 
1:1000 
1:1000 
1:1000 
pCREB Rabbit Epitomics N/A 1:500 
F4/80 Rabbit AbD 1:100 N/A 
Iba 1 Rabbit Wako 1:1000 N/A 
GFAP Rabbit Dako 1:1000 N/A 
NeuN 
NG2 
MBP 
HNE 
Mouse 
Mouse 
Rat 
Rabbit 
Chemicon 
Millipore 
Millipore 
abcam 
1:200 
1:400 
1:400 
1:300 
N/A 
N/A 
N/A 
N/A 
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electrophoresis. Equal amount of RNA from each group was used for Poly(A) tailing 260 
and quantitative reverse transcription consisted of 4 μl 5 × reaction mix, β μl 10 × 261 
SuperScript enzyme mix, and 200 ng total RNA in a final volume of β0 μl. Then real 262 
time PCR was performed using the NCodeTM EXPRESS SYBR GreenERTM 263 
microRNA qRT-PCR Kit (Invitrogen) containing 1 μl of the RT product, 10 μl 264 
EXPRESS SYBR green qRT-PCR SuperMix, 0.4 μl microRNA-specific forward 265 
primer (10 μM), and 0.4 μl universal qPCR primer (10 μM) in a final volume of β0 μl. 266 
PCR cycling began with template denaturation and hot start Taq activation at 95°C for 267 
2 min, followed by 40 cycles of 95°C for 15 sec, and 60°C for 1 min performed in a 268 
CFX96 Real-Time PCR System (BioRad). Beta-actin was used as the internal 269 
standard reference and normalized expressions of targeted genes were calculated 270 
using the comparative CT method and fold changes were derived from the equation 271 
2-ΔΔCt for each gene. All primers were used in this study are list in Table 2. 272 
Table 2. Primer sequences for QRT-PCR analysis 273 
 Accession    
Gene number Forward primer (5’-3’) Reverse Primer (5’-3’) 
AR NM_009658.3 ACGGCTATGGAACAACTA TGTGGCAGTATTCAATCAG 
Arg 1 NM_007482.2 GAACACGGCAGTGGCTTTAAC TGCTTAGCTCTGTCTGCTTTGC
iNOS NM_010927.2 CCCTTCAATGGTTGGTACATGG ACATTGATCTCCGTGACAGCC 
NF-κB NM_008689.2 CCTACGGTGGGATTACATTC CTCCTCGTCATCACTCTTGG 
CREB NM_001037726.1 AGAAGCGGAGTGTTGGTGAGT GGTTACAGTGGGAGCAGATGA
CD86 NM_019388 TTGTGTGTGTTCTGGAAACGGAG AACTTAGAGGCTGTGTTGCTG
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CD206 NM_008625.1 TCTTTGCCTTTCCCAGTCTCC TGACACCCAGCGGAATTTC 
ȕ-actin NM_007393.3 AGAAGGACTCCTATGTGGGTGA CATGAGCTGGGTCATCTTTTCA
Western blotting 274 
Tissue samples about 1 cm of spinal cord with the injured site in middle were lysed by 275 
homogenizing per 100 mg tissues in 1ml RIPA (50 mM Tris-HCl, pH 8.0, 150 mM 276 
NaCl, 1% NP-40, 0.5% Sodium deoxycholate, 0.1% SDS) buffer or the cells in 6-well 277 
plates were lysed in 300μl RIPA buffer containing 1 mM PMSF. Lysates were 278 
centrifuged at 12,000 rpm for 10 min, and the supernatant was collected and added 279 
same volume sample buffer. The protein amount was determined using BSA Protein 280 
Assay Kit (Pierce). Samples with equal amounts of protein were then separated by 281 
10% SDS-PAGE, and electrotransferred onto (300mA for 60min) Polyvinylidene 282 
Fluoride (PVDF) Membranes (Millipore, 0.45μm) with Transblot Turbo (Bio-Rad, 283 
USA). Membranes were incubated with 5% nonfat milk in Tris buffer containing 284 
Tween 20 (TBST; 10 m M Tris-HCl, pH 8.0, 150 mM NaCl, and 0.1% Tween 20) for 285 
2h at RT and incubated with the primary antibodies which listed in Table 1 at 4°C 286 
overnight. Membranes were then washed three times for 10 min with TBST and 287 
probed with relative 2nd antibodies conjugated with horseradish peroxidase (abcam) at 288 
RT for 2 h. Membranes were finally washed three times for 10 min with TBST to 289 
remove unbound 2nd antibodies and visualized using enhanced chemiluminescence 290 
(Thermo Scientific). The density of specific bands was measured using ImageJ 291 
densitometry software and normalized against a loading control (ȕ-actin). 292 
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 293 
Statistical analysis 294 
All statistical analyses were conducted using GraphPad Prism 5.0 (GraphPad 295 
Software). All data are expressed as group mean ± SEM unless otherwise noted. 296 
Comparison of the two groups were performed using independent t tests. Results were 297 
considered statistically significant at p < 0.05. 298 
 299 
Results  300 
Time-course changes in mRNA and protein levels of AR after 301 
SCI 302 
We analyzed time-dependent changes in the expression profiles of AR transcript and 303 
protein between 4 hours and 14 days postinjury (hpi or dpi) using qPCR and WB in 304 
C57BL/6 mice. Starting at 4 hpi, the AR mRNA level began to increase, with a 305 
significant increase 1 dpi and was maintained until 14 dpi according to qPCR results 306 
(Fig. 1a). This result was subsequently confirmed by WB (Fig. 1b, c). The AR protein 307 
was also upregulated in a time-dependent manner after injury (Fig. 1b). The 308 
densitometric ratio of AR/ȕ-actin showed that AR protein clearly increased from 1 dpi 309 
to 14 dpi (Fig. 1c). These results suggest that AR expression was temporally 310 
upregulated after SCI in normal mice. 311 
We next investigated the types of neural cells showing upregulated expression of 312 
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AR following SCI in mice. Based on the above results showing that both mRNA and 313 
protein levels of AR reached a peak 3 dpi in the injured spinal cord, we used the 314 
immunoflorescence double-labeling method to immunostain AR bound to other neural 315 
cell markers, such as NeuN (for neuron), GFAP (for astrocyte), Iba-1 (for 316 
microglia/macrophages), and MBP (for oligodendrocyte), respectively. Neurons 317 
adjacent to the lesion site presented both AR- and NeuN-positive signals (Fig. 1d). 318 
Microglia/macrophages that were Iba-1 positive were also highly expressed AR 319 
adjacent to the lesion site [10, 23] (Fig. 1e). The distal area from the lesion site of the 320 
spinal cord, however, expressed a low level of AR and Iba-1 (Fig. 1e). We also 321 
evaluated AR expression in astrocytes and oligodendrocytes, but no double-labeled 322 
astocytes or oligodendrocytes were observed in injured spinal cord (data not shown). 323 
These results suggest that an injured, and not a healthy spinal cord, induces AR 324 
expression in microglia, macrophages, and neurons, but not in astrocytes or 325 
oligodendrocytes. 326 
M1 polarized microglia/macrophages, which mainly secret pro-inflammatory 327 
cytokines, such as INF-Ȗ and TNF-α, are dominant at early stages in SCI [10, 23]. We 328 
suspected that the pro-inflammatory cytokine environment was likely to cause neural 329 
cells to upregulate AR. We isolated primary neural cells, including astrocytes, 330 
oligodendrocytes, neurons, and microglia, and cultured these cells with cytokines 331 
IFN-Ȗ+ TNF-α stimulation for β4 h in vitro, respectively. Next, we extracted RNA 332 
from the cells and measured AR expression using qPCR. Primary neurons and 333 
microglia (Fig. 1h and i), but not astrocytes or oligodendrocytes (Fig. 1f and g), 334 
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expressed high levels of AR transcripts under proinflammatory cytokine stimulation 335 
(Fig. 1f). In addition, under LPS stimulation, microglia expressed much higher levels 336 
of AR mRNA compared to that under proinflammatory cytokine stimulation (Fig. 1i). 337 
A previous study showed that both IFN-Ȗ and LPS can induce macrophage 338 
polarization to the M1 phenotype via IFN-ȖR and TLR4, respectively [13, 25, 45]. 339 
Thus, our results suggest that AR may play a role in polarization of 340 
microglia/macrophages after SCI. 341 
 342 
AR deficiency promoted locomotor recovery after SCI  343 
AR-deficient mice showed no apparent development, reproductive, or nervous system 344 
abnormalities except for a partially defective urine-concentrating ability [21]. 345 
However, whether AR plays a role in recovery after SCI remained unclear. We 346 
evaluated locomotor recovery based on the BMS locomotor rating scale after SCI 347 
with a severe crush model in AR−/− mice [22, 33]. AR-deficient mice exhibited 348 
significant higher BMS scores beginning at 3 dpi (Fig. 2a). After 21 dpi, hind limb 349 
locomotion appeared to reach a plateau in both AR+/+ and AR−/− mice. At the end of 350 
the 28 dpi assessment period, AR+/+ mice showed a mean score of approximately 4 (n 351 
= 10), while the AR−/− mice had a score of 6.5 (n =8) on the BMS scale (Fig. 2a). To 352 
evaluate the lesion sizes after SCI, we performed LFB staining in spinal cord sections 353 
of AR+/+ and AR-/- mice, respectively. First we compared the lesion areas, which was 354 
evidenced by reduced LFB staining, between AR+/+ and AR−/− mice at 3, 7, and 14 dpi 355 
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(Fig. 2b). At all three time-points, AR−/− mice showed much smaller lesion areas 356 
compared to AR+/+ mice after SCI (Fig. 2c). Thus, these results suggest that AR 357 
deficiency can promote functional recovery after SCI in mice. 358 
 359 
M1/M2 ratio decreased significantly during early stages of 360 
SCI 361 
Microglia/macrophages are critical inflammatory cells which significantly contribute 362 
to the pathological environment in SCI. They can be detrimental or beneficial to 363 
functional recovery after SCI based on their polarized subsets, M1 or M2 [10, 13, 44]. 364 
In fact, there are both M1 and M2 microglia/macrophages present at the injured spinal 365 
cord despite whether it is an early stage or late stage in SCI. The M1/M2 ratio 366 
determines the outcome of microglia/macrophages, which is detrimental or beneficial 367 
for recovery after SCI [10, 23]. We stained injured spinal cord sections with 368 
antibodies of the M1-specific marker iNOS and M2-specific marker Arg1 combined 369 
with microglia and macrophage-specific marker F4/80 or Iba1 in AR+/+ and AR−/− 370 
mice, respectively. In AR−/− mice, the number of iNOS+/F4/80+ cells were less than 371 
those in AR+/+ mice after SCI (Fig. 2d). In contrast, there was a larger number of 372 
Arg1+/Iba1+ cells in AR−/− mice compared with AR+/+ mice after SCI (Fig. 2e). These 373 
results show that more Arg1+, but not iNOS+, microglia/macrophages were present at 374 
the injured site in AR−/− mice after SCI. 375 
In AR+/+ mice, the iNOS mRNA increased rapidly and reached its highest level 376 
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at 1 and 3 dpi. At 14 dpi, iNOS mRNA had nearly returned to normal levels in AR+/+ 377 
mice (Fig. 3a). In AR−/− mice, however, iNOS mRNA showed no significant change 378 
at all time-points compared to the sham group after SCI (Fig. 3a). Comparison of 379 
iNOS mRNA level at 4 hpi and 1, 3, and 7 dpi in AR+/+ with AR−/− mice showed that 380 
iNOS mRNA was clearly higher in AR+/+ mice than in AR−/− mice (Fig. 3a). Another 381 
M1 cell marker, CD86, was also detected after SCI by qPCR. The CD86 mRNA level 382 
differed from the iNOS transcription profile at 14 dpi in AR+/+ mice, which displayed 383 
clear upregulation compared to AR−/− mice (Fig. 3b). In AR+/+ mice, Arg1 mRNA 384 
level increased rapidly over a short period of time post-injury and reached its highest 385 
expression at 3 dpi (Fig. 3c). Arg1 mRNA level decreased suddenly at 7 dpi and 386 
recovered to its normal expression level at 14 dpi in AR+/+ mice Fig. 3c). The Arg1 387 
expression pattern in AR−/− mice was similar to that in AR+/+ after SCI, in which Arg1 388 
mRNA was upregulated rapidly after SCI, reaching its highest expression level at 1 389 
dpi and followed by a decrease in expression; however, the pattern was quite different 390 
for Arg1 mRNA expression between the two types of mice (Fig. 3c). In AR−/− mice, 391 
the Arg1 mRNA level was also decreasing, but it decreased slowly comparing to in 392 
AR+/+ mice at same time-point after SCI (Fig. 3c). The mRNA of CD206, another M2 393 
cell marker, also increased significantly at 1, 3, 7, and 14 dpi in AR−/− mice compared 394 
to in AR+/+ mice after SCI (Fig. 3d).  395 
iNOS protein level was downregulated rapidly after SCI in AR−/− mice, while it 396 
was upregulated post-injury in AR+/+ mice (Fig. 3e and f). In contrast, Arg1 was 397 
rapidly upregulated and then decreased at 14 dpi both in AR+/+ and AR−/− mice (Fig. 398 
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3e and g). However, AR−/− mice expressed more Arg 1 than AR+/+ mice at same 399 
checkpoint post-injury (Fig. 3g). Interestingly, we found that both iNOS and Arg1 400 
levels were higher in AR−/− mice than in AR+/+ mice in the sham groups. It is unclear 401 
whether these results suggest that AR-deficient microglia indicate higher basic 402 
activity. Densitometric analysis showed that iNOS/β-actin was much lower in AR−/− 403 
mice than in AR+/+ mice at same checkpoint post-injury (3f). While densitometic 404 
analysis Arg1/β-actin and the ratio of Arg1/iNOS protein expression was much 405 
higher in AR−/− mice than in AR+/+ mice at same checkpoint post-injury (Fig. 3g and 406 
h). The characteristic markers of M2 macrophages, such as Arg1 and CD206, were 407 
upregulated rather than M1 cell markers, such as, iNOS and CD86, after SCI in AR−/− 408 
mice. This suggests that macrophages and microglia may be polarized to M2 cells at 409 
the lesion site after SCI in AR−/− mice. 410 
 411 
AR deficiency caused NF-κB downregulation and CREB 412 
upregulation after SCI in mice 413 
Several key transcription factors that translate signals in the microenvironment into a 414 
polarized macrophage phenotype are produced according to several reports [25, 45]. 415 
TLR engagement can activate NF-κB and produce inflammation mediators associated 416 
with M1 macrophages [25, 45]. In addition, the CREB-C/enhancer binding protein 417 
(EBP) axis plays an important role in macrophage polarization and induces M2 418 
macrophage-specific gene expression [43]. AR-mediated LPS-induced inflammatory 419 
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signals in macrophages promote NF-κB dependent expression of inflammatory 420 
cytokines and chemokines [37-40]. AR also regulates LPS-mediated inflammation 421 
through the cAMP/PKA/CREB pathway [42]. Thus, we focused on the expression 422 
profiles of NF-κB and CREB after SCI in AR+/+ and AR−/− mice. The mRNA of the 423 
p65 subunit of NF-κB increased gradually postinjury, with AR+/+ mice showing 424 
higher mRNA levels of p65 at 1, 3, and 7 dpi compared with AR−/− mice at same 425 
time-point after SCI (Fig. 4a). Additionally, mRNA levels of CREB were higher at 4 426 
hpi and 1, 3, and 7 dpi in AR−/− mice (Fig. 4b). At 14 dpi, however, the mRNA level 427 
of CREB was lower in AR−/− mice compared to in AR+/+ mice (Fig. 4b). In AR+/+ 428 
mice, the protein level of p65 gradually increased at 1, 3, 7, and 14 dpi (Fig. 4c and e).  429 
In AR−/− mice, however, the profile of p65 continued decreasing after SCI (Fig. 4d 430 
and e). The other transcription factor studied, CREB, also showed a different 431 
expression pattern after SCI in AR+/+ mice and AR−/− mice. In AR+/+ mice, the peak of 432 
CREB expression occurred at 14 dpi, while CREB level was highest at 3 dpi and 433 
decreased at 14 dpi in AR−/− mice (Fig. 4d and f). Amounts of pCREB were always 434 
higher at same time-point after SCI in AR−/− mice compared with in AR+/+ mice (Fig. 435 
4g). Consistent with the higher baseline level of iNOS and Arg 1 (Fig. 3e), the levels 436 
of NF-κB, CREB, and pCREB were also higher at baseline in AR−/− mice (Fig. 4c and 437 
d). These results showed that there were lower levels of the p65 subunit of NF-κB and 438 
higher CREB and pCREB during early stages after SCI in AR−/− mice compared to 439 
those in AR+/+ mice. 440 
 441 
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HNE and CREB were upregulated in microglia following AR 442 
inhibition. 443 
   HNE is one of the products of lipid peroxidation. It undergoes glutathione 444 
S-transferase (GST)-catalyzed conjugation to form GS-HNE, which is further reduced 445 
to GS-DHN (1, 4-dihydroxynonene) by AR [36]. To confirm whether HNE increases 446 
after ARI Fidarestat treatment, we measured the concentration of HNE in the BV2 447 
microglia cell line based on fluorescence using in vitro immunohistochemistry. 448 
Compared with untreated ARI cells, HNE significantly increased in cells following 449 
ARI treatment (Fig. 5A). The concentration of ARI from β0 μM to 40 μM did not 450 
obviously increase the HNE level in a dose-dependent manner (Fig. 5a). We next 451 
detected changes in HNE levels of under β0 μM Fidarestat over time using fluorescent 452 
density scanning with an Infinite M200 PRO (Swiss). HNE level was significantly 453 
increased at 12 h after Fidarestat treatment (Fig. 5b). From 12 h to 48 h after 454 
Fidarestat stimulation, HNE levels were stable at a high level (Fig. 5b). We also 455 
confirmed this phenomena using the microglial cell line N9 (data not shown). These 456 
results suggest that AR inhibition can cause HNE accumulation in microglia.   457 
   Our results described above also showed that AR plays a role in the polarization 458 
process of microglia/macrophages after SCI. To further detect the mechanism of AR 459 
in the regulation of microglia polarization, we used the murine microglial cell line N9 460 
in vitro. N9 cells were treated with dimethylsulfoxide as controls (Fig. 5c, d). 461 
Following LPS stimulation, N9 cells were polarized to the M1 phenotype 462 
characterized by high iNOS and low Arg1 levels with p-NF-κB upregulation (Fig. 5c). 463 
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In contrast, N9 cells following IL-4 stimulation were polarized to the M2 phenotype 464 
characterized by low iNOS and high Arg1 levels similarly to macrophage polarization 465 
(Fig. 5d) [25, 45]. N9 cells were treated with HNE, a substrate of AR, resulting in 466 
upregulation of Arg1 and p-CREB and downregulation of iNOS (Fig. 5c). The ARI, 467 
Fidarestat, which has been examined in phase III clinical trials for diabetic neuropathy, 468 
may also effectively upregulate Arg1 and downregulate iNOS in N9 cells, similarly to 469 
HNE (Fig. 5c) [26, 39, 41, 50]. When N9 cells were stimulated with LPS+ARI, iNOS 470 
and p-NF-κB levels were significantly downregulated, while Arg1 was upregulated 471 
(Fig. 5c). N9 cells were pulsed with a combination of LPS+HNE, and Arg1 and 472 
p-CREB were clearly upregulated, while iNOS was downregulated (Fig. 5c). Thus, 473 
these results suggest that HNE and ARI could induce microglia to upregulate Arg1 474 
and downregulate iNOS, which may occur via the p-CREB pathway.  475 
N9 cells that had been treated with a combination of LPS+ARI, LPS+HNE, and 476 
LPS+HNE+ARI all showed an increase in Arg1 expression. iNOS levels slightly 477 
increased following stimulation with these compounds compared to HNE or ARI 478 
stimulation alone, but decreased significantly compared with LPS stimulation (Fig. 479 
5c). Additionally, the level of p-CREB was clearly increased. However, the level of 480 
p-NF-κB was clearly decreased following stimulation with a combination of these 481 
compounds (Fig. 5c). These results further indicate that HNE and ARI can induce 482 
Arg1 expression through the CREB pathway.  483 
To confirm whether HNE- and ARI-induced Arg1 expression occurred via the 484 
p-CREB pathway, we used the p-CREB-specific inhibitor KG501, which can block 485 
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phosphorylation of CREB, to treat N9 cells in vitro. In N9 cells treated with KG501, 486 
the expression of Arg1 and p-CREB were similar to in cells treated with 487 
dimethylsulfoxide (Fig. 5d). The upregulation of Arg1 induced by HNE and ARI was 488 
stopped in presence of KG501. The p-CREB expression level was also decreased in 489 
the presence of KG501 compared with treatment with HNE or ARI alone (Fig. 5d). 490 
IL-4, which is the prototypical cytokine that polarizes macrophages into the M2 491 
phenotype, significantly induced Arg1 upregulation and slight iNOS downregulation 492 
in N9 cells (Fig. 5d). Combining IL-4 with KG501 to stimulate N9 cells, however, a 493 
slight decrease of Arg1 was observed compared with IL-4 stimulation alone (Fig. 5d). 494 
These results suggest that the HNE and ARI induced Arg1 expression in microglia 495 
occurred through a p-CREB transcriptional factor, but IL-4 did not stimulate 496 
expression through this mechanism.  497 
 498 
Discussion 499 
Inflammation appears to be the most important pathological process during 500 
secondary injury after SCI. Residential microglia and hematogenous macrophages, 501 
which are the main inflammatory subpopulations, from surrounding tissues arrive at 502 
the injury site within hours after the primary injury [14, 34]. The inflammatory 503 
response after SCI is thought as a ‘double-edged sword’, with both neuroprotective 504 
and neurotoxic properties based on the polarized states of microglia/macrophages [10, 505 
23, 44]. In the first few days after injury, iNOS and pro-inflammatory cytokines such 506 
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as TNFα, IL-1ȕ, and IL-6 are upregulated by microglia/macrophages in SCI-induced 507 
aseptic conditions [27, 32]. These proinflammatory cytokines and other mediators 508 
including HMBG1, which are released from dead cells, activating 509 
microglia/macrophages through Toll-like receptors (TLRs), result in NF-κB-mediated 510 
production of proinflammatory cytokines and iNOS activation, the hallmarks of M1 511 
macrophage and microglia activation during early stages of SCI [13, 23, 44]. The 512 
reports of M2 polarization in SCI are controversial. In the contused spinal cord of 513 
mouse, most microglia/macrophages are M1 cells, with only a transient and small 514 
number showing M2 polarization. The expression of one of the classic M2 markers, 515 
Arg1, was transient and returned to normal levels by 14 days post-injury [23]. A 516 
recent study reported accumulation of two distinct subsets of macrophages with 517 
different kinetics. The Ly6chiCx3cr1lo macrophages, which express characteristic M1 518 
markers (IL-1ȕ and TNF-α), are present at 1 dpi and peaked at γ dpi at the injury site 519 
after SCI. Subsequently, Ly6cloCx3cr1hi macrophages, which express characteristic 520 
M2 surface markers (Dectin 1, IL-4Rα and CDβ06), infiltrated beginning at γ dpi and 521 
peaked at 7 dpi at the injury site after spinal cord contused injury [44]. Our results 522 
also showed that both mRNA and protein levels of Arg1 and iNOS are upregulated in 523 
early stages after SCI in AR+/+ mice. However, mRNA and protein levels of Arg1 and 524 
iNOS were expressed with diverging patterns; Arg1 was upregulated, while iNOS was 525 
downregulated during early stages after SCI in AR-deficient mice. The M2-type 526 
microglia/macrophages were dominant at the injured spinal cord in AR−/− mice, 527 
whereas M1 cells dominated in AR+/+ mice at early stages after SCI. This suggests 528 
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that AR plays a critical role in the polarization of microglia/macrophages after SCI in 529 
mice. 530 
AR was described in 1956 by Hers to have glucose-reducing activity [19]. 531 
Recent several reports have shown that AR mediates LPS-induced inflammatory 532 
signals in macrophages [36, 38, 40, 42, 48, 50]. Inhibition of AR by several ARIs 533 
such as sorbinil, tolrestat, and zopolrestat suppresses LPS-induced production of 534 
inflammatory cytokines such as TNF-α, IL-6, IL-1ȕ, IFN-Ȗ, and chemokine MCP-1 in 535 
murine peritoneal macrophages. Inhibition of AR also prevents the production of NO, 536 
and prostaglandin E2 (PGE2) and expression of iNOS and Cox-2 mediated by 537 
inhibiting phosphorylation of IκB-α, IKKα/ȕ, and protein kinase C (PKC) [40]. These 538 
studies demonstrate that AR inhibition or ablation can prevent macrophages 539 
polarization into the M1 phenotype. In this study, we confirmed that AR deficiency 540 
decreases the number of microglia/macrophages with the M1 phenotype after SCI. 541 
AR mediates inflammatory signals in macrophages mainly through regulating 542 
oxidative stress responses [48]. Macrophages are polarized to the M1 response by 543 
either producing pro-inflammatory cytokines or increasing the generation of ROS [29]. 544 
ROS-induced lipid peroxidation-derived compounds such as HNE and their 545 
glutathione-conjugates (e.g. GS-HNE) are produced in large amounts in cells [39, 48]. 546 
AR efficiently catalyzes the reduction of HNE and GS-HNE to 1,4-dihydroxynonene 547 
(DHN) and GS-DHN, respectively with much lower Km values in the micromolar 548 
range (10–γ0 μM) than the Km value for glucose (50–100 mM) [36, 39]. 549 
Pharmacological inhibition or genetic ablation of AR prevents PLC, PKC, and NF-κB 550 
  29 / 40 
 
activation caused by HNE and GS-HNE, but not by GS-DHN [36]. Thus, inhibiting 551 
AR prevent macrophages from polarizing to M1, which may be due to the reduction 552 
in HNE/GS-HNE to DHN/GS-DHN; this can active the redox-sensitive transcriptional 553 
factors NF-κB and AP-1 to upregulate expression of genes characteristic of M1 554 
macrophages [36, 39] (Fig 6a). AR inhibition can prevent LPS-induced 555 
downregulation of cAMP response element modulator (CREM), phosphorylation of 556 
CREB, and DNA-binding of CREB in macrophages [42]. Another report showed that 557 
HNE could induce ATF-2 and CREB-1 phosphorylation to regulate the secretion of 558 
some cytokines [53]. These data show that HNE and GS-HNE can trigger multiple 559 
signaling cascades to modulate inflammatory responses [36, 53]. In this study, we 560 
found that AR deficiency not only decreased M1 polarization, but also increased the 561 
M2 phenotype of microglia/macrophages after SCI. In vitro experiments showed that 562 
inhibiting AR with fidarestat upregulated HNE in microglia. HNE accumulation 563 
induced Arg1 upregulation by activating CREB, which could be specifically inhibited 564 
by KG501 in microglia. However, the upregulation of Arg1 induced by IL-4 and 565 
transcribed by STAT6 was not inhibited by KG501 [45]. Thus, we hypothesize that 566 
AR controls the switch resulting in accumulation of HNE in cells. If AR is sufficient, 567 
HNE/GS-HNE will be reduced to DHN/GS-DHN, which activates NF-κB and AP-1 568 
to polarize microglia to M1 type [38]. However, if AR is inhibited or ablated, 569 
HNE/GS-HNE will be accumulated in the cytoplasm and activate CREB to polarize 570 
microglia to the M2 type [42, 53] (Fig. 6a, b). 571 
CREB is a pivotal transcriptional factor in macrophage polarization that 572 
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promotes activation of M2-associated genes with repressing M1 activation [1, 16, 43]. 573 
CREB induces C/EBPȕ expression, which specifically regulates Mβ-associated genes 574 
[43]. Both STAT6 and C/EBPȕ have recently been shown to be essential for Arg1 575 
expression in macrophages, but in a stimulus-specific manner due to the selective use 576 
of a distinct cis-acting element in the Arg1 promoter [16]. C/EBPȕ is responsible for 577 
Arg1 expression in response to TLR ligands, whereas STAT6 regulates Arg1 578 
expression in response to IL-4 and/or IL-13 stimulation [16, 45]. CREB also shows 579 
anti-inflammatory cytokine expression in macrophage in response to LPS, which is 580 
mediated by the p38 mitogen-activated protein kinase (MAPK) and mitogen- and 581 
stress-activated kinase 1 (MSK1) and MSK2 [1]. As it was shown previously, the 582 
M1-polarized microenvironment with high pro-inflammatory cytokines (e.g. IL-1ȕ 583 
and IL-6) and TLR ligands (e.g. HMGB1) are dominant, which is preferred for 584 
polarizing microglia/macrophages into the M1 type during early stages of SCI [13, 27, 585 
32]. In this study, we found that AR deficiency could switch microglia/macrophages 586 
polarized to the M2 type rather than the M1 type even at early stages of an 587 
M1-polarized microenvironment, such as in injured spinal cord. Thus, it is reasonable 588 
that AR deficiency causes accumulation of HNE in microglia, which stimulates 589 
CREB to regulate the expression of characteristic M2 genes with the repression of 590 
M1-associated genes (Fig. 6 b).  591 
AR can be detected in a number of human and animal tissues including various 592 
regions of the eyes, testis, liver, placenta, ovary, kidney, erythrocyte, cardiac and 593 
skeletal muscle, and the brain [51]. AR is located in the cytoplasm of most cells but is 594 
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not uniformly distributed in all cell types of an organ. For example, in the kidney, AR 595 
is present in the loop of Henle, collecting tubules, outer and inner medulla, but not in 596 
the cortex [52]. In this study, we also found that although the levels of mRNA and 597 
protein of AR are both gradually upregulated after injury in time-dependent manner, 598 
AR is only distributed in microglia, macrophages, and neurons, but not in astrocytes 599 
or oligodendrocytes near the injured site after SCI. Quantitative proteomic analysis of 600 
purified in vivo retinal ganglion cells (RGCs) showed that AR is one of the most 601 
significantly elevated proteins in experimental glaucoma [12]. The roles of AR in the 602 
nervous system primarily result from diabetic complications, such as retinopathy and 603 
neuropathy [12]. Previous studies demonstrated that hyperglycemia-induced oxidative 604 
stress leads to activation of MAPK, which may contribute to neuronal pathogenesis. 605 
Fidarestat, an AR inhibitor, was shown to prevent activation of MAPK and nerve 606 
conduction velocity deficits in diabetes [20, 35]. Studies using AR knockout mice [21] 607 
also demonstrated that AR deficiency could prevent diabetes-induced oxidative stress 608 
in retinal neurons [11]. Moreover, both AR deficiency and AR inhibition reduced 609 
oxidative stress in the peripheral nerves and markedly protected mice from 610 
diabetes-induced functional deficits [20]. However, there have been few reports 611 
regarding the role of AR in neuronal cells in the CNS. In this study, we found that AR 612 
was upregulated in neurons near the lesion site of the spinal cord after injury. The 613 
significance of AR upregulation in neurons after SCI remains unclear. However, we 614 
also found that AR deficiency promotes axonal regeneration of primary cultured 615 
cortical neurons in vitro (data not shown). We suggest that AR plays multiple roles in 616 
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neural and non-neural cells. 617 
AR inhibition is emerging as a promising therapeutic approach in understanding 618 
the cellular and molecular mechanisms of AR [31]. Although ARI-targeted therapies 619 
are currently being evaluated in phase I/II and III studies for diabetes and 620 
endotoxin-related inflammatory diseases, yet they have not achieved worldwide 621 
clinical use in disease management because of limited efficacy and/or unfavorable 622 
adverse effects [31]. To explore the AR-mediated signaling pathway in different 623 
tissues and cells may be critical to increase efficacy and decrease side effects of ARIs 624 
in future. In this study, we found that AR has a critical role in switching 625 
microglia/macrophages polarization after SCI. We suggest that AR inhibition may be 626 
a promising therapeutic method for treating SCI in future. 627 
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 638 
Figure legends 639 
Fig 1. The expression pattern of AR in vivo and in vitro. a, Time-course of AR mRNA 640 
level after SCI. b, Time-course of AR protein level after SCI. c. The densitometric 641 
ratio of AR in Fig. b. d, The co-localization of AR (green)- and Iba1 (red)-positive 642 
cells in the sagittal section of injured spinal cord was stained by IHC. In the first row 643 
panel, the boxed area 1, located near the epicenter of injured spinal cord, is enlarged 644 
in second row panel 1 and the boxed area 2, located at the distal area of injured spinal 645 
cord, is enlarged in third row panel β. Bars are equal to 500 μm and 50 μm, 646 
respectively. e, The co-localization of AR (green) - and NeuN(red)-positive cells in 647 
the coronal section of injured spinal cord was stained by IHC. The boxed area in left 648 
panel is enlarged in the right panel. Bars are equal to β00 μm and 50 μm. f, The 649 
mRNA level of AR in primary cultured astrocytes with stimulation of TNF-α + INF-Ȗ. 650 
g, The mRNA level of AR in primary cultured oligodendrocytes with stimulation of 651 
TNF-α + INF-Ȗ. h, The mRNA level of AR in primary cultured neurons with 652 
stimulation of TNF-α + INF-Ȗ. i, The mRNA level of AR in primary cultured 653 
microglia with stimulation of TNF-α + INF-Ȗ and LPS, respectively. *p < 0.05, **p < 654 
0.01. Iba1= ionized calcium binding adapter molecule 1; NeuN= Neuronal Nuclei. 655 
 656 
Fig 2. AR deficiency promoted locomotion recovery after SCI and induced 657 
microglia/macrophages polarized to M2 in mice. a, BMS score to evaluate locomotion 658 
recovery at different time post injury in AR+/+ and AR−/− mice. b and c, Injured areas 659 
were judged in sagittal sections of injured spinal with LFB staining (b) and calculated 660 
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with statistical analysis in (c) in WT and AR−/− mice. Bar = 500 μm. d, Representative 661 
figures showing the amount of iNOS (green)- and F4/80 (red)-positive cells in the 662 
sections of injured spinal cord in WT and AR−/− mice. Boxed area in each pannel was 663 
enlarged at corner of each panel. Bar = 200 μm. e, The representative figures showing 664 
that the amount of Arg1 (green)- and Iba1 (red)-positive cells in the sections of 665 
injured spinal cord in WT and AR−/− mice. Boxed area in each panel was enlarged at 666 
corner of each panel. Bar = 200 μm. iNOS= inducible nitric oxide synthase; Arg 667 
1=Arginase 1. 668 
 669 
Fig 3. Time-course of the characteristic genes of M1 and M2 expression after SCI in 670 
WT and AR−/− mice. a, Time-course of iNOS mRNA levels after SCI in WT and AR−/− 671 
mice. b, Time-course of CD86 mRNA levels after SCI in WT and AR−/− mice. c, 672 
Time-course of Arg1 mRNA levels after SCI in WT and AR−/− mice. d, Time-course 673 
of CD206 mRNA levels after SCI in WT and AR−/− mice. e, Time-course of iNOS and 674 
Arg1 proteins levels after SCI in WT and AR−/− mice. f, iNOS normalized by β-actin. 675 
g, Arg 1normalized byβ-actin.  h, Time-course of the ratio of Arg1/iNOS in protein 676 
level after SCI in WT and AR−/− mice. *p < 0.05, **p < 0.01, ***p < 0.001. 677 
 678 
Fig 4. Time-course of NF-κB and CREB mRNA and protein levels after SCI in WT 679 
and AR−/− mice. a, Time-course of NF-κB mRNA levels after SCI in WT and AR−/− 680 
mice. b, Time-course of CREB mRNA levels after SCI in WT and AR−/− mice. c, 681 
Time-courses of NF-κB, CREB, and p-CREB protein levels after SCI in WT mice. d, 682 
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Time-courses of NF-κB, CREB, and p-CREB protein levels after SCI in AR−/− mice. e, 683 
NF-κB normalized by β -actin. f, CREB normalized byβ -actin. g, pCREB 684 
normalized byβ-actin. *p < 0.05, **p < 0.01, ***p < 0.001. 685 
 686 
Fig 5. Mechanism of AR in regulating M1/M2 polarization in microglia in vitro. a, 687 
Representative fluorescent photos of HNE levels in BV2 microglial cells under 688 
different dosages of AR inhibitor Fidarestat stimulation in vitro. Bar = 50 μm. b, 689 
Time-course changes of density of fluorescence of HNE in BV2 microglial cells under 690 
20-μM Fidarestat stimulation in vitro. *p < 0.05. c, analysis of the protein levels of 691 
Arg1, iNOS, pCREB, CREB, pNF-κB, and NF-κB in N9 microglial cells under LPS 692 
stimulations combined with ARI and HNE in vitro by western blotting. d, Analysis of 693 
the protein levels of Arg1, iNOS, pCREB, CREB, pNF-κB, and NF-κB in N9 694 
microglial cells under ARI and HNE stimulations combined with KG501 in vitro by 695 
western blotting. Numeric values accompany the representative samples of western 696 
blot indicate the relative expression level obtaining in control cells (treated with 697 
DMSO), normalized by β-actin. 698 
 699 
Fig 6. Schematic presentation of the mechanism of AR in regulation of M1/M2 700 
polarization. a, AR typically reduces HNE/GS-HNE to DHN/GS-DHN which 701 
activates NF-κB and AP1 to induce the M1-associated genes expression. b, In AR 702 
inhibition or AR deficiency, the reduction of AR is decreased and causes the 703 
accumulation of HNE/GS-HNE, which activated CREB to induce the M2-associated 704 
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genes expression.705 
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